Concepedia

Mengyang Chang

MC

5

Publications

212

Citations

5

H-Index

2022

Active since

Affiliations

University of Arizona(Current)

University of Arizona Cancer Center

Mengyang Chang is an author at University of Arizona specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Top concepts

Publications per year

2022–2024

5

Publications

5

Bioorthogonal PROTAC Prodrugs Enabled by On-Target Activation

Mengyang Chang, Feng Gao, Devin Pontigon et al. · Journal of the American Chemical Society · 2023 · 114 citations · Full text

Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation

Mengyang Chang, Yue Dong, Hang Xu et al. · Angewandte Chemie International Edition · 2024 · 35 citations · Full text

, , +20

Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs

Mengyang Chang, Feng Gao, Giri Gnawali et al. · Journal of Medicinal Chemistry · 2024 · 29 citations · Full text

Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery

Jing Chen, Peng Ji, Giri Gnawali et al. · Acta Pharmaceutica Sinica B · 2022 · 22 citations · Full text

MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabilization of p53

Mengyang Chang, Feng Gao, Jing Chen et al. · Acta Materia Medica · 2022 · 12 citations · Full text

Rows per page

1–5 of 5